Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

G D'Haens; S Vermeire; G Lambrecht; F Baert; P Bossuyt; B Pariente; A Buisson; Y Bouhnik; J Filippi; C.J. van der Woude; P Van Hootegem; J Moreau; E Louis; D Franchimont; M Vos; F Mana; L Peyrin-Biroulet; H Brixi; M Allez; P Caenepeel; A Aubourg; B Oldenburg; M Pierik; A van Gils; S Chevret; D Laharie; null Getaid

doi:10.1053/j.gastro.2018.01.004

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

G D'Haens, S Vermeire, G Lambrecht, F Baert, P Bossuyt, B Pariente, A Buisson, Y Bouhnik, J Filippi, C.J. van der Woude, P Van Hootegem, J Moreau, E Louis, D Franchimont, M Vos, F Mana, L Peyrin-Biroulet, H Brixi, M Allez, P CaenepeelA Aubourg, B Oldenburg, M Pierik, A van Gils, S Chevret, D Laharie, Getaid

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

268 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1343-+
Journal	Gastroenterology
Volume	154
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2018.01.004
Publication status	Published - 2018

Research programs

EMC MM-04-20-01

Access to Document

10.1053/j.gastro.2018.01.004

http://hdl.handle.net/1765/105558

Cite this

D'Haens, G., Vermeire, S., Lambrecht, G., Baert, F., Bossuyt, P., Pariente, B., Buisson, A., Bouhnik, Y., Filippi, J., van der Woude, C. J., Van Hootegem, P., Moreau, J., Louis, E., Franchimont, D., Vos, M., Mana, F., Peyrin-Biroulet, L., Brixi, H., Allez, M., ... Getaid (2018). Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. Gastroenterology, 154(5), 1343-+. https://doi.org/10.1053/j.gastro.2018.01.004

@article{d8ba3d770fc94dc096b01b7d72e87503,

title = "Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease",

author = "G D'Haens and S Vermeire and G Lambrecht and F Baert and P Bossuyt and B Pariente and A Buisson and Y Bouhnik and J Filippi and {van der Woude}, C.J. and {Van Hootegem}, P and J Moreau and E Louis and D Franchimont and M Vos and F Mana and L Peyrin-Biroulet and H Brixi and M Allez and P Caenepeel and A Aubourg and B Oldenburg and M Pierik and {van Gils}, A and S Chevret and D Laharie and Getaid",

year = "2018",

doi = "10.1053/j.gastro.2018.01.004",

language = "Undefined/Unknown",

volume = "154",

pages = "1343--+",

journal = "Gastroenterology",

issn = "0016-5085",

number = "5",

}

D'Haens, G, Vermeire, S, Lambrecht, G, Baert, F, Bossuyt, P, Pariente, B, Buisson, A, Bouhnik, Y, Filippi, J, van der Woude, CJ, Van Hootegem, P, Moreau, J, Louis, E, Franchimont, D, Vos, M, Mana, F, Peyrin-Biroulet, L, Brixi, H, Allez, M, Caenepeel, P, Aubourg, A, Oldenburg, B, Pierik, M, van Gils, A, Chevret, S, Laharie, D & Getaid 2018, 'Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease', Gastroenterology, vol. 154, no. 5, pp. 1343-+. https://doi.org/10.1053/j.gastro.2018.01.004

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. / D'Haens, G; Vermeire, S; Lambrecht, G et al.
In: Gastroenterology, Vol. 154, No. 5, 2018, p. 1343-+.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

AU - D'Haens, G

AU - Vermeire, S

AU - Lambrecht, G

AU - Baert, F

AU - Bossuyt, P

AU - Pariente, B

AU - Buisson, A

AU - Bouhnik, Y

AU - Filippi, J

AU - van der Woude, C.J.

AU - Van Hootegem, P

AU - Moreau, J

AU - Louis, E

AU - Franchimont, D

AU - Vos, M

AU - Mana, F

AU - Peyrin-Biroulet, L

AU - Brixi, H

AU - Allez, M

AU - Caenepeel, P

AU - Aubourg, A

AU - Oldenburg, B

AU - Pierik, M

AU - van Gils, A

AU - Chevret, S

AU - Laharie, D

AU - Getaid, null

PY - 2018

Y1 - 2018

U2 - 10.1053/j.gastro.2018.01.004

DO - 10.1053/j.gastro.2018.01.004

M3 - Article

C2 - 29317275

SN - 0016-5085

VL - 154

SP - 1343-+

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -